Plain-English translation of NCT06598280 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Atrial Fibrillation research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether people with atrial fibrillation (an irregular heartbeat) can safely leave the hospital on the same day after a pulmonary vein isolation procedure—a minimally invasive treatment that helps restore normal heart rhythm. The study compares two approaches: same-day discharge using special closure devices and sutures, versus the traditional approach of staying overnight with manual pressure and stitches at the catheter insertion site. Researchers want to see if same-day discharge is just as safe while also making the experience more comfortable and less costly for patients.
Currently, many hospitals keep patients overnight after this procedure out of caution, even though the procedure itself is routine and performed in outpatient settings. This trial exists to determine whether modern closure techniques make overnight stays unnecessary, potentially allowing patients to recover at home while reducing hospital costs and improving quality of life.
You likely qualify if…
You likely don't qualify if…
If you enroll, you'll be randomly assigned to either go home the same day of your ablation procedure (using special sutures to close the catheter site) or stay overnight in the hospital with traditional manual pressure and stitches. Either way, you'll have the pulmonary vein isolation procedure as planned. After that, you'll be monitored for any complications or unexpected medical visits over 30 days, and then followed up for a full year to make sure the treatment is working safely and effectively.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Germany